Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Current Heart Failure Reports
Erschienen in: Current Heart Failure Reports 2/2012

01.06.2012 | Management of Heart Failure (TE Meyer, Section editor)

Cardiac Ultrasound Imaging in Heart Failure: Recent Advances

verfasst von: Umar A. Khan, Gerard P. Aurigemma

Erschienen in: Current Heart Failure Reports | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Several new imaging modalities are being utilized in the management of heart failure. Echocardiography and speckle tracking imaging offer clinician the benefits of easy accessibility, real time data interpretation and objective quantification of heart function. Accordingly, this article reviews the current evidence base related to the use of echocardiography and other advanced ultrasonography techniques in heart failure, and discusses applications as well as limitations of these emerging technologies. The role of cardiac resynchronization therapy (CRT) and implications of the PROSPECT (Predictors of Response to CRT) trial in management of heart failure are also reviewed. The article concludes with a discussion about the evolving role of echocardiography in diagnosis and management of subclinical heart disease, so that preventive strategies may be devised.
Literatur
1.
•• Marwick TH, Raman SV, Carrió I, et al. Recent developments in heart failure imaging. JACC Cardiovasc Imaging. 2010 Apr;3(4):429–39. This is a comprehensive review of updates in heart failure imaging, including advanced techniques.PubMedCrossRef
2.
Aurigemma GP, Zile MR, Gaasch WH, et al. Contractile behavior of the left ventricle in diastolic heart failure: with emphasis on regional systolic function. Circulation. 2006;113(2):296–304.PubMedCrossRef
3.
Marwick TH, Leano RL, Brown J, et al. Myocardial strain measurement with 2-dimensional speckle-tracking echocardiography: definition of normal range. J Am Coll Cardiol Img. 2009;2:80–4.
4.
Pirat B, Khoury DS, Hartley CJ, et al. A novel feature-tracking echocardiographic method for the quantitation of regional myocardial function: validation in an animal model of ischemia reperfusion. J Am Coll Cardiol. 2008;51:651–9.PubMedCrossRef
5.
Mehta N, Vector Velocity Imaging in normal heart. JACC accepted abstract, in press
6.
Rutz AK, Manka R, Kozerke S, et al. Left ventricular dyssynchrony in patients with left bundle branch block and patients after myocardial infarction: integration of mechanics and viability by cardiac magnetic resonance. Eur Heart J. 2009;30:2117–27.PubMedCrossRef
7.
Tanimoto T, Imanishi T, Tanaka A, et al. Bedside assessment of myocardial viability using transmural strain profile in patients with ST elevation myocardial infarction: comparison with cardiac magnetic resonance imaging. J Am Soc Echocardiogr. 2009;22(9):1015–21.PubMedCrossRef
8.
Kurt M, Wang J, Torre-Amione G, Nagueh SF. Left atrial function in diastolic heart failure. Circ Cardiovasc Imaging. 2009;2(1):10–5.PubMedCrossRef
9.
Ommen SR, Nishimura RA, Appleton CP, et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation. 2000;102(15):1788–94.PubMed
10.
•• Nagueh S, Appleton C, Gillebert T, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Journal of the American Society of Echocardiography. February 2009, Vol. 22, Issue 2, Pages 107–133. These are the most current guidelines for diagnosis of diastolic heart failure. PubMedCrossRef
11.
12.
Aurigemma GP, Zile MR, Gaasch WH. Lack of relationship between Doppler indices of diastolic function and left ventricular pressure transients in patients with definite diastolic heart failure. Am Heart J. 2004;148(3):E12.PubMedCrossRef
13.
Hillis GS, Møller JE, Pellikka PA, et al. Noninvasive estimation of left ventricular filling pressure by E/E' is a powerful predictor of survival after acute myocardial infarction. J Am Coll Cardiol. 2004;43(3):360–7.PubMedCrossRef
14.
Mullens W, Borowski AG, Curtin RJ, et al. Tissue Doppler imaging in the estimation of intracardiac filling pressure in decompensated patients with advanced systolic heart failure. Circulation. 2009;119:62–70.PubMedCrossRef
15.
Stevens SM, Farzaneh-Far R, Na B, et al. Development of an echocardiographic risk-stratification index to predict heart failure in patients with stable coronary artery disease: the Heart and Soul study. JACC Cardiovasc Imaging. 2009;2(1):11–20.PubMedCrossRef
16.
Tan YT, Wenzelburger F, Lee E, et al. The pathophysiology of heart failure with normal ejection fraction: exercise echocardiography reveals complex abnormalities of both systolic and diastolic ventricular function involving torsion, untwist, and longitudinal motion. J Am Coll Cardiol. 2009;54:36–46.PubMedCrossRef
17.
Abhayaratna WP, Seward JB, Appleton CP, et al. Left atrial size: physiologic determinants and clinical applications. J Am Coll Cardiol. 2006;47:2357–63.PubMedCrossRef
18.
Gottdiener JS, Reda DJ, Williams DW, et al. Left atrial size in hypertensive men: influence of obesity, race and age; Department of Veterans Affairs cooperative study group on antihypertensive agents. J Am Coll Cardiol. 1997;29:651–8.PubMedCrossRef
19.
Lester SJ, Ryan EW, Schiller NB, et al. Best method in clinical practice and in research studies to determine left atrial size. Am J Cardiol. 1999;84:829–32.PubMedCrossRef
20.
Pritchett AM, Jacobsen SJ, Mahoney DW, et al. Left atrial volume as an index of left atrial size: a population-based study. J Am Coll Cardiol. 2003;41:1036–43.PubMedCrossRef
21.
Tsang TS, Abhayaratna WP, Barnes ME, et al. Prediction of cardiovascular outcomes with left atrial size: is volume superior to area or diameter. J Am Coll Cardiol. 2006;47:1018–23.PubMedCrossRef
22.
Keller AM, Gopal AS, King DL. Left and right atrial volume by freehand three-dimensional echocardiography: in vivo validation using magnetic resonance imaging. Eur J Echo. 2000;1:55–65.CrossRef
23.
Jenkins C, Bricknell K, Marwick TH. Use of real-time three dimensional echocardiography to measure left atrial volume: comparison with other echocardiographic techniques. J Am Soc Echocardiogr. 2005;18:991–7.PubMedCrossRef
24.
Benjamin EJ, D'Agostino RB, Belanger AJ, et al. Left atrial size and the risk of stroke and death: the Framingham Heart Study. Circulation. 1995;92:835–41.PubMed
25.
Triposkiadis F, Tentolouris K, Androulakis A, et al. Left atrial mechanical function in the healthy elderly: new insights from a combined assessment of changes in atrial volume and transmitral flow velocity. J Am Soc Echocardiogr. 1995;8:801–9.PubMedCrossRef
26.
Nikitin NP, Witte KKA, Thackray SDR, et al. Effect of age and sex on left atrial morphology and function. Eur J Echocardiogr. 2003;4:36–42.PubMedCrossRef
27.
Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part II: the aging heart in health: links to heart disease. Circulation. 2003;107:346–54.PubMedCrossRef
28.
Pritchett AM, Mahoney DW, Jacobsen SJ, et al. Diastolic dysfunction and left atrial volume: a population-based study. J Am Coll Cardiol. 2005;45:87–92.PubMedCrossRef
29.
Tsang TSM, Barnes ME, Gersh BJ, et al. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol. 2002;90:1284–9.PubMedCrossRef
30.
Paulus WJ, Tschope C, Sanderson JE, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J. 2007;28:2539–50.PubMedCrossRef
31.
Sohn M, Chai M, Lee M, et al. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol. 1997;30:474–80.PubMedCrossRef
32.
Sirbu C, Herbots L, D'hooge J, et al. Feasibility of strain and strain rate imaging for the assessment of regional left atrial deformation: a study in normal subjects. Eur J Echo. 2006;7(3):199–208.CrossRef
33.
Cameli M, Caputo M, Mondillo S, et al. Feasibility and reference values of left atrial longitudinal strain imaging by two-dimensional speckle tracking. Cardiovasc Ultrasound. 2009;7:6.PubMedCrossRef
34.
Marwick TH, Leano RL, Brown J, et al. Myocardial strain measurement with 2-dimensional speckle-tracking echocardiography: definition of normal range. JACC Cardiovasc Imaging. 2009;2(1):80–4.PubMedCrossRef
35.
Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. N Engl J Med. 2004;350(21):2140–50.PubMedCrossRef
36.
Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure: Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. N Engl J Med. 2005;352(15):1539–49.PubMedCrossRef
37.
Chung ES, Leon AR, Tavazzi L, et al. Results of the predictors of response to CRT (PROSPECT) trial. Circulation. 2008;117(20):2608–16. Only large sized randomized performed with echocardiographic evaluation.PubMedCrossRef
38.
Bax JJ, Gorcsan 3rd J. Echocardiography and noninvasive imaging in cardiac resynchronization therapy: results of the PROSPECT (Predictors of Response to Cardiac Resynchronization Therapy) study in perspective. J Am Coll Cardiol. 2009;53(21):1933–43.PubMedCrossRef
39.
Sanderson JE. Echocardiography for cardiac resynchronization therapy selection: fatally flawed or misjudged? J Am Coll Cardiol. 2009;53(21):1960–4.PubMedCrossRef
40.
Miyazaki C, Powell BD, Bruce CJ, et al. Comparison of echocardiographic dyssynchrony assessment by tissue velocity and strain imaging in subjects with or without systolic dysfunction and with or without left bundle-branch block. Circulation. 2008;117(20):2617–25.PubMedCrossRef
41.
Tanaka H, Nesser HJ, Buck T, et al. Dyssynchrony by speckle-tracking echocardiography and response to cardiac resynchronization therapy: results of the Speckle Tracking and Resynchronization (STAR) study. Eur Heart J. 2010;31(14):1690–700.PubMedCrossRef
42.
Delgado V, Ypenburg C, van Bommel R. Assessment of left ventricular dyssynchrony by speckle tracking strain imaging comparison between longitudinal, circumferential, and radial strain in cardiac resynchronization therapy. J Am Coll Cardiol. 2008;51:1944–52.PubMedCrossRef
43.
Gorcsan 3rd J, Tanabe M, Bleeker GB, et al. Combined longitudinal and radial dyssynchrony predicts ventricular response after resynchronization therapy. J Am Coll Cardiol. 2007;50(15):1476–83.PubMedCrossRef
44.
Li CH, Carreras F, Leta R, et al. Mechanical left ventricular dyssynchrony detection by endocardium displacement analysis with 3D speckle tracking technology. Int J Cardiovasc Imaging. 2010 Aug 14
45.
Parsai C, Bijnens B, Sutherland GR, et al. Toward understanding response to cardiac resynchronization therapy: left ventricular dyssynchrony is only one of multiple mechanisms. Eur Heart J. 2009;30(8):940–9.PubMedCrossRef
46.
Solomon SD, Janardhanan R, Verma A, et al. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial. Lancet. 2007;369(9579):2079–87.PubMedCrossRef
47.
Narayanan A, Aurigemma GP, Chinali M, et al. Cardiac mechanics in mild hypertensive heart disease: a speckle-strain imaging study. Circ Cardiovasc Imaging. 2009;2(5):382–90.PubMedCrossRef
48.
Chinali M, de Simone G, Roman MJ, et al. Cardiac markers of pre-clinical disease in adolescents with the metabolic syndrome: the Strong heart study. J Am Coll Cardiol. 2008;52:932–8.PubMedCrossRef
49.
Bahrami H, Bluemke DA, Kronmal R, et al. Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol. 2008;51:1775–83.PubMedCrossRef
Metadaten
Titel
Cardiac Ultrasound Imaging in Heart Failure: Recent Advances
verfasst von
Umar A. Khan
Gerard P. Aurigemma
Publikationsdatum
01.06.2012
Verlag
Current Science Inc.
Erschienen in
Current Heart Failure Reports / Ausgabe 2/2012
Print ISSN: 1546-9530
Elektronische ISSN: 1546-9549
DOI
https://doi.org/10.1007/s11897-012-0085-9

Weitere Artikel der Ausgabe 2/2012

Current Heart Failure Reports 2/2012 Zur Ausgabe

Pathophysiology: Neuroendocrine, Vascular, and Metabolic Factors (SD Katz, Section editor)

TNF Revisited: Osteoprotegerin and TNF-related Molecules in Heart Failure

Pathophysiology: Neuroendocrine, Vascular, and Metabolic Factors (SD Katz, Section editor)

Receptor for Advanced Glycation End Products (RAGE) and Implications for the Pathophysiology of Heart Failure

Pathophysiology: Neuroendocrine, Vascular, and Metabolic Factors (SD Katz, Section editor)

The Neurohormonal Network in the RAAS Can Bend Before Breaking

Management of Heart Failure (TE Meyer, Section editor)

Role of Heart Rate as a Marker and Mediator of Poor Outcome for Patients with Heart Failure

Management of Heart Failure (T Meyer, Section Editor)

Chemotherapy-Induced Cardiotoxicity

Management of Heart Failure (T Meyer, Section Editor)

A Rational Approach to Assess Volume Status in Patients with Decompensated Heart Failure

Neu im Fachgebiet Kardiologie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen